Efficacy and safety of sofosbuvir based therapy in patients with chronic hepatitis C infection: A real-life cohort study
Latest Information Update: 26 May 2016
Price :
$35 *
At a glance
- Drugs Sofosbuvir (Primary) ; Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 26 May 2016 New trial record